Celldex Therapeutics (CLDX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-1990 | 12-1989 | 12-1988 | 12-1987 | 12-1986 | |
| Sales | 10,240 | 10,935 | 7,671 | 4,567 | 378 |
| Cost of Goods | 1,665 | 1,301 | 1,145 | 0 | 146 |
| Gross Profit | 8,576 | 9,634 | 6,526 | 4,567 | 232 |
| Operating Expenses | 13,590 | 11,802 | 8,433 | 6,568 | 3,852 |
| Operating Income | -4,350 | -1,867 | -1,762 | -2,001 | -3,474 |
| Other Income | 909 | 822 | 705 | 809 | 2,649 |
| Pre-tax Income | -3,441 | -1,044 | -1,058 | -1,192 | -825 |
| Net Income Continuous | -3,441 | -1,044 | -1,058 | -1,192 | -825 |
| Net Income | $-3,441 | $-1,044 | $-1,058 | $-1,192 | $-825 |
| EPS Basic Total Ops | -64.11 | -22.59 | -23.05 | -26.04 | -18.06 |
| EPS Basic Continuous Ops | -58.62 | -19.74 | -22.89 | -26.02 | -18.01 |
| EPS Diluted Total Ops | -58.63 | -19.74 | -22.89 | -26.02 | -18.01 |
| EPS Diluted Continuous Ops | -58.62 | -19.74 | -22.89 | -26.02 | -18.01 |
| EBITDA(a) | $-4,350 | $-1,867 | $-1,762 | $-2,001 | $-3,474 |